BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26783755)

  • 1. Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner.
    Fekry B; Esmaeilniakooshkghazi A; Krupenko SA; Krupenko NI
    PLoS One; 2016; 11(1):e0146618. PubMed ID: 26783755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate stress induces apoptosis via p53-dependent de novo ceramide synthesis and up-regulation of ceramide synthase 6.
    Hoeferlin LA; Fekry B; Ogretmen B; Krupenko SA; Krupenko NI
    J Biol Chem; 2013 May; 288(18):12880-90. PubMed ID: 23519469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
    Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
    Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress.
    Fekry B; Jeffries KA; Esmaeilniakooshkghazi A; Ogretmen B; Krupenko SA; Krupenko NI
    J Biol Chem; 2016 Aug; 291(32):16586-96. PubMed ID: 27302066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
    Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
    J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network.
    Senkal CE; Ponnusamy S; Manevich Y; Meyers-Needham M; Saddoughi SA; Mukhopadyay A; Dent P; Bielawski J; Ogretmen B
    J Biol Chem; 2011 Dec; 286(49):42446-42458. PubMed ID: 22013072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.
    Hartmann D; Wegner MS; Wanger RA; Ferreirós N; Schreiber Y; Lucks J; Schiffmann S; Geisslinger G; Grösch S
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1195-203. PubMed ID: 23538298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.
    Senkal CE; Ponnusamy S; Bielawski J; Hannun YA; Ogretmen B
    FASEB J; 2010 Jan; 24(1):296-308. PubMed ID: 19723703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia.
    Verlekar D; Wei SJ; Cho H; Yang S; Kang MH
    Cell Death Dis; 2018 Sep; 9(9):925. PubMed ID: 30206207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide.
    Schiffmann S; Ziebell S; Sandner J; Birod K; Deckmann K; Hartmann D; Rode S; Schmidt H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2010 Dec; 80(11):1632-40. PubMed ID: 20735991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
    Suzuki M; Cao K; Kato S; Komizu Y; Mizutani N; Tanaka K; Arima C; Tai MC; Yanagisawa K; Togawa N; Shiraishi T; Usami N; Taniguchi T; Fukui T; Yokoi K; Wakahara K; Hasegawa Y; Mizutani Y; Igarashi Y; Inokuchi J; Iwaki S; Fujii S; Satou A; Matsumoto Y; Ueoka R; Tamiya-Koizumi K; Murate T; Nakamura M; Kyogashima M; Takahashi T
    J Clin Invest; 2016 Jan; 126(1):254-65. PubMed ID: 26650179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT1/FOXP3 axis-mediated expression of CerS6 promotes p53 mutant pancreatic tumorigenesis.
    Qi D; Song X; Xue C; Yao W; Shen P; Yu H; Zhang Z
    Cancer Lett; 2021 Dec; 522():105-118. PubMed ID: 34343636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury.
    Liu Y; Sun Z; Sun Q; Wang L; Wang C; Li Y; Ma C; Shi W; Zhang G; Dong Y; Zhang X; Cong B
    Lipids Health Dis; 2024 Mar; 23(1):68. PubMed ID: 38431645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide synthase 6 mediates sex-specific metabolic response to dietary folic acid in mice.
    Barron K; Ogretmen B; Krupenko N
    J Nutr Biochem; 2021 Dec; 98():108832. PubMed ID: 34358645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
    Turpin SM; Nicholls HT; Willmes DM; Mourier A; Brodesser S; Wunderlich CM; Mauer J; Xu E; Hammerschmidt P; Brönneke HS; Trifunovic A; LoSasso G; Wunderlich FT; Kornfeld JW; Blüher M; Krönke M; Brüning JC
    Cell Metab; 2014 Oct; 20(4):678-86. PubMed ID: 25295788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis.
    Novgorodov SA; Chudakova DA; Wheeler BW; Bielawski J; Kindy MS; Obeid LM; Gudz TI
    J Biol Chem; 2011 Feb; 286(6):4644-58. PubMed ID: 21148554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis.
    Scheffel MJ; Helke K; Lu P; Bowers JS; Ogretmen B; Garrett-Mayer E; Paulos CM; Voelkel-Johnson C
    Sci Rep; 2017 Nov; 7(1):15552. PubMed ID: 29138469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramide synthase 6 predicts the prognosis of human gastric cancer: It functions as an oncoprotein by dysregulating the SOCS2/JAK2/STAT3 pathway.
    Uen YH; Fang CL; Lin CC; Hseu YC; Hung ST; Sun DP; Lin KY
    Mol Carcinog; 2018 Dec; 57(12):1675-1689. PubMed ID: 30129684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A.
    Tang Y; Cao K; Wang Q; Chen J; Liu R; Wang S; Zhou J; Xie H
    Oncol Rep; 2016 May; 35(5):2907-15. PubMed ID: 26934938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide synthase 2-C
    Zhang X; Sakamoto W; Canals D; Ishibashi M; Matsuda M; Nishida K; Toyoshima M; Shigeta S; Taniguchi M; Senkal CE; Okazaki T; Yaegashi N; Hannun YA; Nabe T; Kitatani K
    FASEB J; 2021 Feb; 35(2):e21287. PubMed ID: 33423335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.